This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why CNO Financial (CNO) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MetLife (MET) Q2 Earnings Beat on Favorable Underwriting Results
by Zacks Equity Research
MetLife's (MET) second-quarter 2024 results benefit from improved variable investment income, strong volumes and strength in the Group Benefits segment. However, poor performance in the RIS segment partially offset the results.
MGIC Investment (MTG) Beats Q2 Earnings, Raises Dividend
by Zacks Equity Research
MGIC Investment (MTG) Q2 results reflect higher premiums written, improved net investment income and lower underwriting and other expenses, partially offset by lower insurance in force.
Radian Group (RDN) Q2 Earnings Top Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Radian Group (RDN) Q2 results reflect solid performance across both Mortgage and All Other segments, improved investment income and premiums earned, partially offset by higher expenses.
CNO Financial (CNO) Q2 Earnings Beat Estimates, '24 EPS View Up
by Zacks Equity Research
CNO Financial (CNO) raises its 2024 EPS in the range of $3.30-$3.50, indicating an increase of 10% from the 2023 figure of $3.09.
Compared to Estimates, CNO (CNO) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for CNO (CNO) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
CNO Financial (CNO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 45.83% and 16.39%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Cognizant's (CTSH) second-quarter performance will likely reflect strength from an expanding clientele and a robust pipeline that includes a favorable mix of new opportunities.
Lemonade (LMND) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Lemonade (LMND) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNO Financial (CNO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cognizant (CTSH) Expands Neuro Suite With Edge AI Platform
by Zacks Equity Research
Cognizant (CTSH) introduces Neuro Edge. The suite empowers businesses with real-time, secure AI at the edge for faster decisions and operational efficiency across industries.
Assurant (AIZ) Down 2.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is American International Group (AIG) Up 0.2% Since Last Earnings Report?
by Zacks Equity Research
American International Group (AIG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO (CNO) Up 6.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO Financial (CNO) Q1 Earnings Miss Estimates, Revenues Up Y/Y (Revised)
by Zacks Equity Research
CNO Financial (CNO) reaffirms its 2024 EPS guidance in the range of $3.10-$3.30, indicating an increase from the 2023 figure of $3.09.
CNO Financial (CNO) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Radian Group (RDN) Q1 Earnings Beat on Higher Premiums
by Zacks Equity Research
Radian Group's (RDN) Q1 results reflect improved persistency and a rise in premiums and insurance written, partially offset by higher expenses.
CNO Financial (CNO) Q1 Earnings Miss on Higher Expenses
by Zacks Equity Research
CNO Financial (CNO) reaffirms its 2024 EPS guidance in the range of $3.10-$3.30, which indicates an increase from the 2023 figure of $3.09.
CNO (CNO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for CNO (CNO) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CNO Financial (CNO) Q1 Earnings Miss Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of -18.75% and 23.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Prudential (PRU) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Prudential (PRU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNO Financial (CNO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
5 Dividend-Paying Multiline Insurers Worth Watching
by Tanuka De
Multiline insurers like MetLife (MET), Prudential Financial (PRU), MGIC Investment (MTG), CNO Financial (CNO) and Old Republic (ORI), which have a solid dividend history, offer a breather amid volatility.
Here's Why You Should Retain PRA Group (PRAA) Stock for Now
by Zacks Equity Research
Growing portfolio supply in the United States, coupled with pricing tailwinds and improvement in cash efficiency ratio, poise PRA Group (PRAA) well for growth.